Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Feb 2025 for Sensei Biotherapeutics, Inc., €1,037. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Edward van der Horst: trading record in brief
Edward van der Horst discloses dealings in Faeth Therapeutics, Inc. to SEC (Form 4). Between 15 February 2023 and 19 February 2025, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 26 February 2025, reports a share grant of €1,037 in Faeth Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Edward van der Horst
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,276 shares@ US$0.4766.3% of flowCommon StockSEC:0001415889-25-005727:0
2,843 shares@ US$0.7912.7% of flowCommon StockSEC:0001415889-24-004236:0
9,525 shares@ US$1.5081.0% of flowCommon StockSEC:0001209191-23-048967:0
23,565 shares0Common StockSEC:0001209191-23-010736:0
4 of 4 declarations
